Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MODIFI-RC-II)

NCT06958432 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

430

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer
Neoadjuvant Therapies
Immune Checkpoint Therapy
Radiotherapy

Interventions

COMBINATION_PRODUCT: Node-Sparing Radiotherapy plus Chemotherapy and PD-1 inhibitor
COMBINATION_PRODUCT: Conventional Radiotherapy plus Chemotherapy and PD-1 inhibitor

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University